Franciosi V; Sgargi P; Melegari E; Bozzani F; Gnappi D; Michiara M; Vasini G; Salvagni S; Bacchini GP; Ghisoni F; De Lisi V; Ardizzoni A, PALLIATIVE CARE FOR TERMINALLY-ILL CANCER PATIENTS RESIDENT IN PARMA PROVINCE: RATES OF HOSPITALISATION, USE OF HOME CARE AND HOSPICE SERVICES AND PRESCRIPTION OF CHEMOTHERAPY NEAR TO DEATH, «ANNALS OF ONCOLOGY», 2009, 20, pp. 1 - 1 [abstract]
Zilembo N; Gridelli C; De Marinis F; Crino L; Ardizzoni A; Caprioli A; Pela R; Marangolo M; Buscarino C; Barni S, SURVIVAL OF ITALIAN PATIENTS NEWLY DIAGNOSED STAGE IIIB-IV NSCLC STARTING PHARMACOLOGICAL TREATMENT: 1-YEAR FOLLOW UP RESULTS FROM THE SUN (SURVEY IN THE LUNG CANCER MANAGEMENT) OBSERVATIONAL STUDY, «ANNALS OF ONCOLOGY», 2009, 20, pp. 1 - 1 [abstract]
Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A, Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report, «LUNG CANCER», 2009, 65, pp. 251 - 253 [replica/breve intervento]
Parra HJS; Ippolito M; Tiseo M; Cosentino S; Pumo V; Bordonaro R; Latteri F; Ardizzoni A; Bortesi B; Spadaro P, Usefulness of 18FDG-positron emission tomography for early prediction of response in non-small cell lung cancer (NSCLC) patients treated with erlotinib: results of a pilot study, «JOURNAL OF THORACIC ONCOLOGY», 2009, 4, pp. S375 - S376 [abstract]
Cascinu S; Berardi R; Salvagni S; Beretta GD; Catalano V; Pucci F; Sobrero A; Tagliaferri P; Labianca R; Scartozzi M; Crocicchio F; Mari E; Ardizzoni A, A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation, «BRITISH JOURNAL OF CANCER», 2008, 98, pp. 71 - 76 [replica/breve intervento]
FV. Negri; N. Campanini; R. Camisa; F. Pucci; S. Bui; G.Ceccon; R.Martinelli; Pl. Losardo; P. Grafa; C. Bordi; S. Casinu; Ardizzoni A, Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy, «BRITISH JOURNAL OF CANCER», 2008, 98, pp. 143 - 147 [replica/breve intervento]
Bozzetti C; Tiseo M; Lagrasta C; Nizzoli R; Guazzi A; Leonardi F; Gasparro D; Spiritelli E; Rusca M; Carbognani P; Majori M; Franciosi V; Rindi G; Ardizzoni A, Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites, «JOURNAL OF THORACIC ONCOLOGY», 2008, 3, pp. 18 - 22 [replica/breve intervento]
Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A, Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer, «JOURNAL OF THORACIC ONCOLOGY», 2008, 3, pp. 1104 - 1111 [replica/breve intervento]
Musolino A; Naldi N; Bortesi B; Pezzuolo D; Capelletti M; Missale G; Laccabue D; Zerbini A; Camisa R; Bisagni G; Neri TM; Ardizzoni A, Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer, «JOURNAL OF CLINICAL ONCOLOGY», 2008, 26, pp. 1789 - 1796 [replica/breve intervento]
Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Gross F; Paganuzzi M, Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer, «ANTICANCER RESEARCH», 2008, 28, pp. 507 - 513 [replica/breve intervento]
Tiseo M; Spiritelli E; Capelletti M; Rindi G; Ardizzoni A, Refractory pleural small cell carcinoma in never smoker. A case report, «TUMORI», 2008, 94, pp. 434 - 436 [replica/breve intervento]
Gridelli C; Ardizzoni A; Ciardiello F; Hanna N; Heymach JV; Perrone F; Rosell R; Shepherd FA; Thatcher N; Vansteenkiste J; De Petris L; Di Maio M; De Marinis F, Second-line treatment of advanced non-small cell lung cancer, «JOURNAL OF THORACIC ONCOLOGY», 2008, 3, pp. 430 - 440 [replica/breve intervento]
Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A, BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study, «THE BREAST», 2007, 16, pp. 280 - 292 [replica/breve intervento]
Loprevite M; Tiseo M; Chiaramondia M; Capelletti M; Bozzetti C; Bortesi B; Naldi N; Nizzoli R; Dadati P; Kunkl A; Zennaro D; Lagrasta C; Campanini N; Spiritelli E; Camisa R; Grossi F; Rindi G; Franciosi V; Ardizzoni A, Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non-small cell lung cancer, «CLINICAL CANCER RESEARCH», 2007, 13, pp. 6518 - 6526 [replica/breve intervento]
Doria S; Prochilo T; Cafferata MA; Tiseo M; Ardizzoni A; Baldini E, Cisplatin plus docetaxel as second-line treatment in metastatic non-small-cell lung cancer (NSCLC), «ANNALS OF ONCOLOGY», 2007, 18, pp. 28 - 29 [abstract]
